|Bid||0.0900 x N/A|
|Ask||0.1000 x N/A|
|Day's Range||0.0900 - 0.1000|
|52 Week Range||0.0250 - 0.1600|
|Beta (5Y Monthly)||1.57|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Predictmedix AI Inc. (CSE:PMED)(OTCQB:PMEDF)(FRA:3QP) (the "Company" or "Predictmedix") today announced that visas have been granted for a strategic visit to India. The primary purpose of the company's executives' visit is to engage with institutional partners and government officials in India, with a keen focus on ensuring seamless integration and scalable deployment of Predictmedix's cutting-edge contactless AI solutions.
Predictmedix AI Inc. (CSE:PMED)(OTCQB:PMEDF)(FRA:3QP) (the "Company" or "Predictmedix") is proud to announce its recent feature in the prestigious Toronto Star newspaper, accompanied by a compelling interview with the company's COO, Dr. Rahul Kushwah. This exciting development marks a significant milestone in Predictmedix's journey, enhancing the company's visibility and attracting both business opportunities and investor attention.
Predictmedix AI Inc. (CSE:PMED)(OTCQB:PMEDF)(FRA:3QP) (the "Company" or "Predictmedix") today provided an update on its achievements and developments so far in 2023.